CSG Heads to AUSA Debut With Drone-Interceptor Project, Caspian Plant Plan and a Wall Street Doubt to Answer

CSG makes its AUSA debut October 12–14 and joins the SwarmShot counter-drone effort, as BofA warns ammunition margins may not hold.

Washington's annual AUSA defense exhibition, running October 12–14, will serve as the stage for CSG's first appearance at the U.S. Army gathering — and as the last public word from management before the company enters its customary quiet period ahead of quarterly results. The Czech-based defense group plans to display hardware from its CSG Defence Systems and CSG Ammo+ divisions, including Tatra Force military vehicles, as it works to deepen its footprint in North America.

The exhibition announcement carried no fresh firm orders, but it lands alongside a separate move into new technology territory. On Thursday, CSG's Federal Ammunition subsidiary joined the development of SwarmShot, a reusable, airborne interceptor system built with U.S. partners O.F. Mossberg & Sons and Palladyne AI. Neither a timeline nor financial terms were disclosed. According to media reports, the concept pairs specialized shotshell ammunition and a lightweight weapon module with autonomous flight control — a combination aimed at the rapidly growing global appetite for cost-effective counter-drone solutions.

A Caspian Production Bet

Beyond the U.S. showcase, CSG is pushing ahead with its project pipeline. On September 30, the company unveiled plans for a second joint venture in Azerbaijan, targeting the gradual localization of self-propelled howitzer production, with manufacturing slated to begin in 2027. CSG put the business potential at EUR 1.8 billion over seven years, and the joint company is to be established in December.

In the Baltics, meanwhile, Tatra Defence Systems acts as prime contractor on the Latvian armed forces' modernization program for artillery systems and multiple rocket launchers. CSG joined that effort roughly two weeks ago, a stretch during which the share price has slipped 4.7 percent.

BofA's Margin Warning

The expansion into new areas comes against a shifting market backdrop. On October 1, Bank of America analyst David Holmes initiated coverage with an "Underperform" rating and a EUR 13 price target, arguing that CSG's ammunition margins — recently above 30 percent — are unlikely to hold at that level as European production capacity ramps up and demand shifts from acute wartime needs toward stockpiling.

That reassessment cooled the optimism that had built among market participants. The stock finished Friday's session at EUR 14.06, down 14 percent over the past 30 days and 61 percent below its 52-week high of EUR 36.05.

Investors get their next hard data point on November 11, when CSG publishes its interim report for the third quarter. Whether the American technology initiatives can reignite the growth narrative will depend on future contract signings.